Palonosetron

 
0.0 (0)
This page displays reviews written by users of all forms of Palonosetron. You can also choose to see reviews only for a specific medical condition or brand name.
Brand Names
Medical Conditions

More about Palonosetron

What is/are Palonosetron?

Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). It is the most effective of the 5-HT3 antagonists in controlling delayed CINV—nausea and vomiting that appear more than 24 hours after the first dose of a course of chemotherapy—and is the only drug of its class approved for this use by the U.S. Food and Drug Administration.[1] As of 2008, it is the most recent 5-HT3 antagonist to enter clinical use.

Palonosetron is administered intravenously, as a single dose, 30 minutes before chemotherapy,[1] or as a single oral capsule one hour before chemotherapy.[2] The oral formulation was approved on August 22, 2008 for prevention of acute CINV alone, as a large clinical trial did not show oral administration to be as effective as intravenous use against delayed CINV.

Adverse effects

Less serious side effects of palonosetron may include:

  •     Headache;
  •     Constipation; or
  •     Tired feeling.

This article uses material from the Wikipedia article Palonosetron, which is released under the Creative Commons Attribution-Share-Alike License 3.0.

Reviews for Palonosetron

See reviews for a different combination of brand names and medical conditions:
     
There are no user reviews for this listing.
Already have an account?
Ratings
Overall satisfaction
Efficacy
Lack of side effects
Relevant Brand Name and Medical Condition
Additional Information
Please tell us about your experience with this medicine